Barclays »

Aytu Biopharma shares owned by Barclays

Quarter-by-quarter ownership of Aytu Biopharma (AYTU) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Aytu Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Aytu Biopharma held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aytu Biopharma by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $108 50 2.16
2025-09-30 $2 1 2.00
2025-06-30 $0 1 0.00
2025-03-31 $0 1 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Aytu Biopharma

Nantahala Capital Management
Stonepine Capital Management
AWM Investment Company
Vanguard Capital Management
Crown Advisors Management
Diadema Partners
Two Sigma Investments
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Vanguard Fiduciary Trust
Dimensional Fund Advisors
Persistent Asset Partners
Northern Trust
Bellevue Asset Management

View all funds holding Aytu Biopharma